baber/WOPTO huggingface dataset:
Patent CA-2422444-A1 (CA)
Inventor: RASMUSSEN HARRY
IPC: H01G9/20
Filed: 2000-09-06
Abstract: L'invention concerne un procédé et un appareil (2) permettant de produire de l'énergie électrique grâce aux propriétés semi-conductrices du silicium selon un procédé galvanique/chimique, dans lequel la silice à l'état naturel (SiO¿2?) est écrasée ou granulée et disposée dans un plateau (10) sur une membrane (9) consistant en un film de plastique non conducteur semi-perméable, qui est couvert par une solution constituée d'un mélange de, par exemple, 1l d'acide phosphorique anhydre (H¿3?PO¿4?), 0,25 g d'iode (J), 50 g d'acide borique anhydre (B¿2?O¿3?) et 15 g d'oxyde de titane. Sous la membrane (9), au fond du plateau (10), se trouve une solution aqueuse pauvre de phosphate de potassium, par exemple, ainsi qu'une électrode de carbone constituant une borne électrique (7), le plateau (10) étant couvert par un élément en plaque, perforé ou en treillis, d'une matière électriquement conductrice, constituant une deuxième borne électrique (12). Un certain nombre de cellules (8) en forme de plateau sont placées, de façon à présenter un espacement mutuel, dans un châssis (6) de manière à être électriquement séparées. Une batterie de cellules est formée par connexion en parallèle des cellules (8) individuelles. Le côté supérieur des cellules respectives est éclairé grâce à des lampes flash (14) disposées au dessus d'elles et déclenchées de façon apériodique par des circuits (15) de déclenchement, le déclenchement du flash étant commandé par un circuit comparateur et un circuit de référence, de manière que le déclenchement des lampes (14) flash respectives soit déterminé par la tension de sortie fournie par les cellules respectives (8), l'énergie électrique produite étant de préférence transformée en énergie thermique dans un appareil de chauffage à eau électrique, dont le thermostat de commande forme de préférence une partie d'un circuit de commande, et les cellules ou au moins leur contenu, constitué de granulés de silice préparés, sont remplacés selon les besoins.
Patent CA-2422836-A1 (CA)
Inventor: HOPKINS JONATHAN L
IPC: B64C1/14
Filed: 2003-03-20
Abstract: A readily attachable window assembly for efficient installation and maintenance of aircraft windows is provided. The aircraft has a sidewall having an inner perimeter that defines an opening. The window assembly includes an outer window frame. A center window frame is attached to the outer window frame, and an inner window frame is attached to the center window frame. The inner window frame is readily attachable to the sidewall adjacent to the opening of the inner perimeter. The inner window frame includes a releasable coupling mechanism that includes first and second engaging mechanisms that positionally lock the first mechanism to the second mechanism via a torsion spring assembly and engageable teeth of each mechanism. The first engaging mechanism is locked onto the sidewall when torque is applied through at least one pinhole. The window assembly is disengaged by disengaging the first and second engaging mechanisms via a disengagement tab.
Patent CA-2423455-A1 (CA)
Inventor: BRADLEY SCOTT J
IPC: B65D77/20
Filed: 2003-03-26
Abstract: A food package is provided that includes a compartment an which food items are carried and a holder portion which allows a user to place the food item therein with the food item held in a stationary position. The food holder can serve as a staging area for combining the food item with other food items or can be used as a placement location for a partially eaten food item. In the preferred multicompartment package, an improved back card construction is also disclosed.
Patent CA-2423595-A1 (CA)
Inventor: SILVER DAVID M
IPC: A61P27/02
Filed: 2001-10-12
Abstract: The present invention is directed to a method to prevent or reduce postoperative corneal subepithelial haze after excimer laser photorefractive keratectomy (PRK), laser in situ keratomileusis (LASIK) surgery. According to the method, a therapeutically effective amount of one or more plasminogen activators, most preferably urokinase (uPA), is administered topically to the surface of the affected eye at levels between 0.1 and 2,500 IU/ml, about eight to twelve times on the day of surgery, and four to eight times per day for about the next six to twelve days thereafter. The most preferred therapeutic amount is from about 0.1-1 IU uPA/ml, and also 1-10 IU/ml. Plasminogen activators that can be used in the inventions include urokinase, prourokinase, tissue plasminogen activator, streptokinase and mutants thereof. The invention also covers topical ophthalmic compositions that include one or more plasminogen activators, most preferably uPA, to prevent or reduce postoperative corneal subepithelial haze.
Patent CA-2424394-A1 (CA)
Inventor: UPTON ZEE
IPC: A61P43/00
Filed: 2001-09-24
Abstract: An isolated protein complex is provided which includes a growth factor, growth factor binding protein and vitronectin. Preferably, the isolated protein complex includes an insulin-like growth factor-I, insulin-like growth factor binding protein-3 or insulin-like growth factor binding protein-5 and vitronectin. Also provided are methods of modulating cell proliferation and/or migration by administering said protein complex for the purposes of wound healing, skin repair and tissue replacement therapy. Conversely, by using agents that disrupt growth factor protein complexes formed in vivo, growth factor-driven cell proliferation and/or migration may be suppressed such as for the purposes of treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring.
Patent CA-2429883-A1 (CA)
Title: Content filtering for web browsing
Inventor: BEILINSON CRAIG ADAM
IPC: G06F17/30
Filed: 2003-05-27
Abstract: The present invention provides a system and method for controlling whether a user may access certain Internet sites when using a computer. The system and method are earned out on a personal computer having a local ratings cache, a cache refresher, a local ratings interpreter and an allow-block list. When the computer user attempts to access an Internet site referenced by a specified Uniform Resource Locator ("URL"), the invention determines whether the URL is referenced on the allow-block list and, if so, allows or disallows access to the site referenced by the URL  accordingly. If the URL is not referenced on the allow-block list, the invention obtains a content category from either the local ratings cache or, if not contained therein, a ratings service. If the content category may be viewed by a person in the user's age group, as determined by reference to an age group map cross-referencing age group to permissibly viewable categories for each such age group, the local ratings interpreter permits access to the Internet site referenced by the specified URL;  otherwise, access is not allowed. A copy of the settings for the user, such as the age group, the allow-block list and the age group map, are stored on a content settings service so that the user's settings can be accessed and used on any computer the user is operating.
Patent CA-2429952-A1 (CA)
Title: Method for generating immortal dendritic cell lines
Inventor: PESCHON JACQUES JEAN
IPC: A61K39/00
Filed: 2001-12-07
Abstract: Immortalized mammalian dendritic cell lines are provided that have characteristics of functional, mature dendritic cells; defined by surface phenotype, constitutive and inducible gene expression patterns, and functional effects on T lymphocytes. The cell lines are capable of continuous in vitro proliferation for extended periods of time. Of particular interest is the ability of the cell lines to present antigen in a stimulatory manner to naïve T cells. The dendritic cell lines are useful in gene discovery, the generation of dendritic cell subset-specific antibodies and probes; defining stages of dendritic cell differentiation and maturation; for induction of antigen specific stimulation of lymphocytes; for dissection of antigen specific anergy or tolerance in lymphocytes; for characterization of dendritic cell-natural killer cell interactions; for in vitro and in vivo analyses of dendritic cell- endothelial cell interactions; and for screening assays.
Patent CA-2430120-A1 (CA)
Inventor: MCDYSAN DAVE
IPC: H04L12/26
Filed: 2001-11-28
Abstract: A network access system includes an external processor and a programmable access device (PAD) (40a, 40b). The external processor (42) transmits a control message to the PAD (40a, 40b) to establish a configuration of the PAD.  The PAD then communicates messages to the external processor (42) for service processing in accordance with the configuration. To limit the communication of network messages from the PAD to the external processor, the PAD can send a message setting message inteface flags in the PAD. The external processor may also transmit a monitor control message to the PAD to establish a configuration of a monitor in the PAD. The PAD then communicates reporting messages to the external processor in response to the configuration of the monitor.
Patent CA-2434575-A1 (CA)
Title: Vehicule-jouet
Inventor: MALEIKA HUBERTUS
IPC: A63H17/00
Filed: 2001-12-27
Abstract: L'invention concerne un véhicule-jouet, notamment pour circuits automobiles à guidage sur rails, qui comprend un moteur d'entraînement (10) comportant un arbre primaire (12), ainsi qu'un essieu commandé (14) muni de roues. Une transmission (16) est disposée entre l'arbre primaire (12) et l'essieu commandé (14), et ladite transmission (16) se présente sous forme de mécanisme de changement de vitesse (16) commuté par le sens de rotation du moteur d'entraînement (10).
Patent CA-2436967-A1 (CA)
Title: Supporting bracket assembly for a horizontal lifeline cable
Inventor: LUKE SIMON
IPC: A62B35/00
Filed: 2001-11-26
Abstract: A supporting bracket assembly for a horizontal lifeline cable (4) comprises a base plate (14), bracket means (24) and holding means (28) for the cable. The base plate (14) is provided for securing to a structure (6). The bracket means (24) is secured to the base plate and adapted for frictionally restrained pivotability with respect to the base plate and the holding means (28) for the cable (4) is secured to the bracket means (24). In this way, dynamic loading of the cable (4) results in pivoting of the bracket means (24), against frictional restraint, from a first position (36) into a second position (38).
Patent CA-2437102-A1 (CA)
Title: Optical alignment system for power tool
Inventor: CARROLL CRAIG ALLEN
IPC: G01B11/27
Filed: 2003-08-13
Abstract: A power tool having a work surface and a spindle attached to the power tool and defining an axis of operation of the power tool. In one embodiment, the power tool may include a bracket above the work surface. The bracket may include first and second bracket receptacles and first and second holders movably supported in the first and second bracket receptacles. A first laser generator may be mounted in the first holder at a first angle relative to an axis of the first holder, and it may adjustably project a first fan beam. A second laser generator may be mounted in the send holder at a second angle relative to an axis of the second holder, and it may adjustably project a second fan beam. The first and second fan beams may be adjusted to intersect along the axis of operation of the power tool.
Patent CA-2440488-A1 (CA)
Title: Process and device for manufacturing free-flowing metal foam
Inventor: DOBESBERGER FRANK
IPC: C22C1/08
Filed: 2003-09-08
Abstract: The invention relates to a process to manufacture free-flowing metal foam with a monomodal distribution of the dimensions of the cavities as well as to a device to supply the same. The invention provides for a gas to be introduced into a foamable molten metal (4) from at least two neighboring similarly dimensioned feed pipes projecting into a metallurgical vessel, and bubbles to be formed therein in the area of the projecting pipe ends, whereby a coherent foam formation is obtained with abutting areas of the bubble surfaces and with forming particle-containing interstructures, and this is developed further. The device is characterized by at least two feed pipes for gas projecting into a foamable melt, which feed pipes are next to one another at a distance from one another.
Patent CA-2440936-A1 (CA)
Inventor: PANGAUD NICOLAS
IPC: G06F13/376
Filed: 2003-01-17
Abstract: The invention concerns a method for identification by a host computer avoiding collision of elements enabling identification of the elements by said computer, each of the elements bearing an identification number ranging between 0 and a maximum value (MAX), and comprising the following steps: a) transmission by the host computer of a request instruction designed to be received and recognized by every element; b) transmission by the host computer of an anti-collision instruction comprising an identification attempt numeric value; c) reply by every element having an identification number not greater than the identification attempt numeric value; and d) detecting a collision between several elements when the host computer receives several replies and transmission of another anti-collision instruction in accordance with a specific algorithm, or selecting the element by its identification number when there is no reply.
Patent CA-2442484-A1 (CA)
Inventor: LOMBARDO LOUIS J
IPC: C07D413/10
Filed: 2002-03-26
Abstract: L'invention concerne des composés représentés par la formule (I) et des sels pharmaceutiquement acceptables de ceux-ci. Ces composés induisent un arrêt mitotique et sont par conséquent utiles comme anticancéreux. Ils sont également utiles pour traiter d'autres maladies pouvant être traitées par un arrêt mitotique induit.
Patent CA-2447554-A1 (CA)
Inventor: GO GIOK DJIEN
IPC: B62D25/12
Filed: 2000-05-13
Abstract: A conventional warning device of a transport system, additional warning ligh ts and an audible device are assembled together to form a visible and audible system. In the case of an accident and/or fire this system automatically turns on the warning lights, which war n drivers of oncoming transport systems and help the users, who are the passengers, nonparticipants, crew members and/or rescue workers, find the doors and door-release levers of a door-detachment device and gives the users via the loudspeakers instructions, based on a tex t data in several languages, of how to behave, to operate the door-release levers for detachin g the doors, jammed and/or remaining locked, from the vehicle body and to egress out of t he transport system therethrough, The system is equipped with a minor current circuit and/or rechargeable batteries to ensure the power supply when the power supply of a car battery must be cut off in accidents.
Patent CA-2448427-A1 (CA)
Inventor: BONVENTRE JOSEPH
IPC: C07K14/705
Filed: 2002-05-31
Abstract: Cette invention concerne des anticorps qui inhibent la libération protéolytique du polypeptide KIM-1 soluble à partir de cellules exprimant KIM-1. Sont également décrites des méthodes d'utilisation des anticorps dans le but d'empêcher la libération du 'polypeptide KIM-1.
Patent CA-2449959-A1 (CA)
Inventor: JONLI ODD MAGNE
IPC: B23K9/00
Filed: 2003-11-18
Abstract: A method for conductively connecting first and second electrical conductors (2, 3) is described which consist of different materials. In carrying out the method the ends of the first and second conductors are brought into mechanical contact with each other in an overlapping position. The first and second conductors (2, 3) then are connected to each other by welding without feeding of additional welding material.  Finally the overlapping area (4) is formed mechanically to achieve a smooth width transition between the first and second conductors (2, 3).
Patent CA-2451122-A1 (CA)
Title: A process for the isomerization of a vinylidene olefin
Inventor: DOLL MICHAEL JOSEPH
IPC: C07C11/113
Filed: 2002-06-20
Abstract: A process for the double bond isomerization of a vinylidene olefin, comprising contacting a feed comprising the vinylidene olefin with an isomerization catalyst which comprises a molecular sieve in an acidic form, which molecular sieve comprises pores which have a pore size of more than 0.6 nm; and a process for treating an olefin mixture which comprises a linear .alpha.-olefin and a vinylidene olefin which is isomeric to the linear .alpha.-olefin and which is of the general formula CH2=C(R1)R2, wherein R1 represents an ethyl group and R2 represents a linear 1-alkyl group, which process comprises isomerizing the vinylidene olefin to form a double bond isomer of the vinylidene olefine by contacting a feed comprising the olefin mixture with an isomerization catalyst which comprises a molecular sieve in an acidic form, which molecular sieve comprises pores which have a pore size of more than 0.6 nm, and separating the linear .alpha.-olefin from the double bond isomer of the vinylidene olefin.
Patent CA-2451686-A1 (CA)
Inventor: NI DONGHUI
IPC: A61K48/00
Filed: 2002-06-21
Abstract: Novel GAVE3 polypeptides, proteins and nucleic acid molecules are provided. In addition to isolated, full-length GAVE3 proteins, isolated GAVE3 fusion proteins, antigenic peptides and anti-GAVE3 antibodies are taught. GAVE3, recombinant expression vectors, host cells into that the expression vectors have been introduced and non-human transgenic animals in that a GAVE3 gene h as been introduced or disrupted are taught. Diagnostic, screening and therapeut ic methods utilizing compositions of the invention also are provided.
Patent CA-2451738-A1 (CA)
Title: Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals using 2-amino-2'-deoxyadenosine
Inventor: RENZI PAOLO
IPC: A61P17/00
Filed: 2002-07-08
Abstract: The invention relates to the use of nucleotide substitutes for increasing the in vivo efficacy of nucleic acid molecules and also for inhibiting inflammation in mammals. More particularly, the present invention relates to the use of 2'6'diaminopurine (DAP) and analogs thereof per se in anti-inflammatory compositions, and also for preparing nucleic acid molecules having an increased in vivo physiological efficiency and a reduced toxicity as compared to conventional oligos. The invention is particularly useful for the preparation of antisense oligonucleotides for treating pulmonary/respiratory diseases such as cystic fibrosis, asthma, chronic bronchitis, chronic obstructive lung disease, eosinophilic bronchitis, allergies, allergic rhinitis, pulmonary fibrosis, adult respiratory distress syndrome, sinusitis, respiratory syncytial virus or other viral respiratory tract infection and cancer.
Patent CA-2452365-A1 (CA)
Inventor: TOMAS JORGE
IPC: A47K3/024
Filed: 2002-07-01
Abstract: A baby bath seat assembly includes a support member 30 having a mounting bracket 34 that clamps onto a tube wall 18 and carrying a support 36 that extends downwardly into the tub. The support 31 carries a base 38 on which the seat 40 is mounted to turn through approximately 180~, and a detent mechanism 110 releasably locks the seat in any selected position.
Patent CA-2457077-A1 (CA)
Inventor: KUOSA HARRI
IPC: D21G1/00
Filed: 2002-08-07
Abstract: The invention concerns a calender, especially a soft calender, including a body structure (10) and at least two roller sets (11; 12), wherein there is at least one calendering nip (N1, N2, N3, N4) formed in between two rollers (13, 14; 14, 15; 16, 17; 17, 18).Of the rollers forming the nip at least one is a roller with a soft surface (13, 15; 16, 18) and the other roller is a heating roller (14, 17). The calender body structure (10) is formed with a stepped shape in such a way that the rollers sets (11, 12) can belocated in an upper and a lower place of location (21) on the sameside of the body.
Patent CA-2461636-A1 (CA)
Inventor: DUNCAN JAMES P
IPC: A61F2/46
Filed: 2002-09-24
Abstract: The present invention is directed to a surgical instrument assembly that includes an operative element and an insertion instrument removably engageable to the operative element. The insertion instrument is positionable in a patient with the operative element engaged thereto to position the operative element at an operative site in the patient. A transfer instrument is removably engageable to the operative element when the operative instrument is located at the operative site. The insertion instrument can then be removed.  Methods for using the surgical instrument assembly are also disclosed.
Patent CA-2462853-A1 (CA)
Inventor: MANNERS CAMERON
IPC: F16L55/163
Filed: 2002-10-03
Abstract: An installation assembly (20) for installing a liner (L) in a pipeline (P) comprises a double bladder assembly (22) including an inner bladder (26) having an installation end (26b) and a retrieval end (26c). An outer bladder (28) surrounds the inner bladder. The ends of the inner and outer bladders are coupled together adjacent the installation end via an inversion element (30).  The inner bladder is coupled to an air source at its retrieval end and the outer bladder adjacent the retrieval end is free. Following installation and curing of the liner, the bladder assembly is retrieved by pulling on the retrieval end of the inner bladder, and upon retrieval, the outer bladder is inverted.
Patent CA-2463081-A1 (CA)
Title: Touch free dispenser
Inventor: COGGER JOHN J
IPC: A47K5/122
Filed: 2002-10-11
Abstract: A touch free dispenser includes a sealed collapsible bottle assembly (22) fo r containing a dispensable fluid, the assembly including a collapsible contain er (24) with a depending coupler (44), a fluid pump (50) disposed within the coupler and a dispensing tip, in fluid communication with the pump and container, for both activating the pump and dispensing the fluid.
Patent CA-2464736-A1 (CA)
Title: Beta-secretase inhibitors and methods of use
Inventor: TURNER ROBERT T III
IPC: C07D213/40
Filed: 2002-10-23
Abstract: Compounds inhibit memapsin 2 .beta.-secretase activity and selectively inhibit memapsin 2 .beta.-secretase activity relative to memapsin 1 .beta.-secretase activity. The compounds are employed in methods to inhibit memapsin 2 .beta.-secretase activity, in the treatment of Alzheimer's disease, in the inhibition of hydrolysis of a .beta.-secretase site of a .beta.-amyloid precursor protein and to decrease .beta.-amyloid protein in in vitro samples and in mammals.  Proteins of memapsin 2 associated with compounds of the invention are crystallized.
Patent CA-2465579-A1 (CA)
Inventor: WILLIAMSON CHARLES G
IPC: H05B6/68
Filed: 2002-10-30
Abstract: The invention may be broadly conceptualized as an approach in which a microwave oven (120) receives a plurality of program recipes from a network that are executed by scanning with a scanner (1326) a symbol and associating the scanned symbol with one of the plurality of program recipes while keeping a real-time clock (1308) synchronized and correctly set by receiving period time synchronization messages.
Patent CA-2468703-A1 (CA)
Title: Controlled release polymeric compositions of bone growth promoting compounds
Inventor: DUNN RICHARD LEE
IPC: A61K9/00
Filed: 2002-11-20
Abstract: The present invention is directed to an improved system for controlled relea se of a bone growth promoting compound and to a flowable composition for its formation. The flowable composition is composed of a bone growth promoting compound, a thermoplastic polymer and an organic solvent. The flowable composition is capable of forming a biodegradable and/or bioerodible microporous, solid polymer matrix. The matrix is useful as an implant in patients (humans and animals) for delivery of a bone growth promoting compou nd to certain tissues.